Log In
BCIQ
Print this Print this
 

SOD1 ALS diagnostic blood test

  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
DescriptionDiagnostic blood test which measures misfolded SOD1 for amyotrophic lateral sclerosis (ALS)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentDiscovery
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose amyotrophic lateral sclerosis (ALS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today